Lynn Bayless

Vice President Regulatory Affairs, Gene Therapy- Insmed, Inc.

Role
Vice President, Regulatory Affairs, Gene Therapy at Insmed Incorporated
Location
Marlborough, MA, US
LinkedIn followers
500 followers

About Lynn Bayless

Vice President and Head of Regulatory Affairs with 20+ years’ Global regulatory experience across an array of therapeutic areas including oncology, ophthalmology, neurology, and metabolic diseases. Regulatory expertise in clinical and nonclinical with a strong working knowledge of regulatory CMC. Tenure predominantly in the orphan disease space. Leadership representation across entire depth of company including Executive Leadership Team, Board of Directors meetings, and Research Steering Committee. Successfully developed regulatory strategies for biologics, including gene and cell therapies and combination products. Expertise in Global regulatory submissions including, but not limited to IND/CTAs, NDA/BLA/MAA, Orphan drug applications, RMAT, rare pediatric disease designation requests, and post approval supplements. Successfully led strategic discussions with FDA/EMA/MHRA/Health Canada that resulted in advancement of programs per predefined timelines. Built high-performing regulatory affair departments from the ground-up. Passionate about mentoring and coaching staff to reach their fullest professional potential.

Experience

  1. Vice President, Regulatory Affairs, Gene Therapy

    Insmed Incorporated

    Aug 2024 — Present

    I am thrilled to join a company with a patient-centered mission.

Education

  • Quinnipiac University

    BS, Major: Laboratory Animal Technology/ Pre-Vet Minor: Microbiology

    1983 — 1987

  • Massachusetts College of Pharmacy and Health Sciences

    MS, Regulatory Affairs and Health Policy

    2000 — 2002

Skills

  • Nda
  • Rare Diseases
  • CRO
  • Medical Devices
  • Clinical Research
  • Clinical Development
  • Vendor Management
  • Research
  • Compliance
  • Strategy
  • Regulatory Affairs
  • Cmc
  • Biotechnology
  • Drug Development
  • Gcp
  • Biopharmaceuticals
  • Technical Writing
  • Clinical Trials
  • Hipaa
  • R&D
  • Ectd
  • Cross-Functional Team Leadership
  • Orphan Drugs
  • Ctms
  • Gmp
  • Pharmaceutical Industry
  • Sop
  • Fda
  • Regulatory Requirements
  • Ind
  • Biologics
  • Regulatory Submissions
  • Drug Discovery

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Lynn Bayless — Vice President, Regulatory Affairs, Gene Therapy at Insmed Incorporated in Marlborough, MA, US | Unifers